FDA warns Shenzhen Sunell over unapproved COVID-19 fever-screening cameras sold in U.S. without clearance.
What happened
FDA reviewed the company’s website on February 26, 2021, and found it offered four fever-screening cameras for sale in the U.S. with statements that they are intended for COVID-19 mitigation, prevention, treatment, diagnosis, or cure. FDA said the cameras lacked marketing approval, clearance, or authorization and that the firm had not notified FDA of intent to market them. FDA also noted the devices can scan multiple people at once, which can create public health risks if temperatures are incorrectly assessed.
What FDA found
The website statements show the screening cameras are intended for COVID-19 use, making them devices under the law.
section 201(h) of the Act, 21 U.S.C. § 321(h)The firm offers the fever-screening cameras for COVID-19 use without FDA marketing approval, clearance, or authorization, making them adulterated.
section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B)The firm did not submit a 510(k) premarket notification to FDA for the devices, making them misbranded.
section 502(o) of the Act, 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)The products are introduced or delivered for introduction into interstate commerce even though they are adulterated and misbranded.
section 301(a) of the Act, 21 U.S.C. § 331(a)
What FDA wants
FDA tells the company to take immediate action to stop selling the cameras for COVID-19 use and to email COVID-19-Task-Force-CDRH@fda.hhs.gov within 48 hours with the specific steps taken and documentation showing how recurrence will be prevented.
Who should pay attention
- U.S. distributors and resellers of thermal cameras
- employers and venues using fever-screening systems
- regulatory teams for COVID-19 screening-device makers
This is a summary. Read the original letter on fda.gov.